期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

小细胞肺癌诊断与治疗

Diagnosis and treatment in therapy of small-cell lung cancer
原文传递
导出
摘要 近几年国内外学者在小细胞肺癌（SCLC）的诊断分期、化放疗顺序、放疗参与综合治疗时间以及新的化疗药物、靶向药物应用等方面进行了广泛研究，尤其在广泛期SCLC化疗缓解后行脑预防照射的研究、新的化疗药物如伊立替康、口服拓扑替康、培美曲塞的应用等方面进行了有益的探索。但在有关分期、局限期SCLC化放疗时间等问题尚有争议，需进一步探讨和研究。 Recently, staging, chemoradiotherapy schedule, new chemotherapy agents and application of targeted therapy drugs are widely investigated in small cell lung cancer（ SCLC ）. Some progresses are achieved in prophylactic cranial irradiation of extensive stage and some new chemotherapy agents such as irinotecan, oral topotecan and pemetrexed etc are widely investigated. There are still some disputes about staging, the timing of chemoradiotherapy in localized SCLC and so on.
作者 柳影(综述) 程颖(审校)
机构地区 吉林省肿瘤医院内一科
出处 《国际肿瘤学杂志》 CAS 2008年第7期509-512,共4页 Journal of International Oncology
关键词 癌 小细胞肺 肿瘤分期 治疗 Carcinoma, small cell lung Neoplasm staging Therapy
分类号 R734-2 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1Darling GE. Staging of the patient with small cell lung cancer. Chest Surg Clin N Am, 1997, 7( 1 ) :81-94.
  • 2Shepherd FA, Crowley J, Van Houtte P, et al. The International Association for the Study of Lung Cancer lung cancer staging project:proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol. 2007, 2 (12) :1067-1077.
  • 3Groome PA, Bolejack V, Crowley JJ , et al. The IASLC I,ung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol, 2007,2 (8) :694-705.
  • 4Brink T, Schumacher M, Mix S, et al. Impact of [18F] FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging, 2004, 31 (12) : 1614-1620.
  • 5Fried DB, Morris DE, Poole C, et al. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol, 2004, 22 ( 23 ) :4837-4845.
  • 6Pijls-Johannesma MC, De Ruysscher D, Lambin P, et al. Early versus late chest radiotherapy for limited stage small cell lung cancer. Cochrane Database Syst Rev, 2005, 25 ( 1 ) : CD004700.
  • 7De Ruysscher D, Pijls-Johannesma M, Vansteenkiste J, et al. Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limitedstage, small- cell lung cancer. Ann Oncol, 2006, 17(4) :543-552.
  • 8De Ruysscher D, Pijls-Johannesma M, Bentzen SM, et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited- disease small- cell lung cancer. J Clin Oncol, 2006, 24 (7) : 1057-1063.
  • 9Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med, 2007, 357 (7) :664-672.
  • 10Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatln compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med, 2002,346(2) :85-91.
国际肿瘤学杂志
2008年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部